HIV Prevention
Conditions
Keywords
PrEP, Pharmacy, HIV prevention
Brief summary
Quantify the impact of an online Virtual Community of Practice (VCoP) to increase pharmacist knowledge and accelerate provision of pre-exposure prophylaxis (PrEP) for HIV prevention.
Detailed description
Communities of practice unite individuals and provide opportunity to share knowledge, develop skills, and reduce isolation. We will conduct a Type 3 hybrid effectiveness-implementation trial to evaluate implementation outcomes (e.g. acceptability, feasibility, and adoption) and effectiveness (e.g. number of PrEP initiations). The primary outcome will compare time to first PrEP prescription among 180 pharmacies randomized to an enhanced standard of care arm plus or minus VCoP access. We hypothesize that pharmacies with VCoP access will create their programs and provide their first oral PrEP prescriptions in less time than pharmacies without VCoP access.
Interventions
BEHAVIORALVirtual Community of Practice
Healthcare communities of practice (CoPs) are becoming increasingly popular. CoPs unite individuals with common interests and provide opportunity to collaboratively learn and develop skills to improve professional practice, and reduce isolation. CoPs can play a role when educational needs cannot be satisfied by traditional methods. With advances in technology and the COVID-19 pandemic, virtual communities of practice (VCoPs) have spread across the globe. One of the primary benefits of online VCoPs is expanded potential for professional development and remote networking. VCoP members can use asynchronous communication to develop relationships and learn from peers who have experience with laws, policies, insurance companies and other healthcare institutions across the U.S. This education and peer support provided by VCoPs could be particularly beneficial for pharmacists in rural areas or in EHE jurisdictions without access to similar resources as academic or urban pharmacists.
BEHAVIORALEnhanced Standard of Care
A self-guided business and program planning. This arm will be sent a syllabus introducing them to the six-month business and program plan. Assignments will be delivered every other week, focusing on clinical, epidemiological, and business related educational tasks to be completed to prepare pharmacist to offer PrEP. The study team will be available for email assistance.
Sponsors
University of Washington
National Institute of Mental Health (NIMH)
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Pharmacists or pharmacy staff working at pharmacy in U.S. * Pharmacy is not currently providing PrEP
Exclusion criteria
Any potential participants unable to fully complete the proposed study activities due to health or other concerns will be excluded in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to first PrEP prescription | for 2 years from participant enrollment. | Time to first PrEP prescription by participating pharmacists as self-reported. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| PrEP Clinics Started | within 2 years of participant enrollment | Total number of PrEP Clinics started by participants |
| Total numbers of PrEP prescriptions initiated | within 2 years of participant enrollment | Total numbers of PrEP prescriptions initiated by participants |
| characteristics of PrEP patients | 2 years post-enrollment | characteristics of PrEP patients |
Contacts
CONTACTLisa Niemann
PRINCIPAL_INVESTIGATORJoanne Stekler, MD, MPH
University of Washington
Outcome results
None listed